Related Experiment Video

Updated: Mar 17, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.6K

The cancer stem-cell signaling network and resistance to therapy

A Carnero1, Y Garcia-Mayea2, C Mir2

  • 1Instituto de Biomedicina de Sevilla (IBIS/HUVR/CSIC/Universidad de Sevilla), Molecular Biology of Cancer Group, Oncohematology and Genetic Department, Campus HUVR, Edificio IBIS, Avda. Manuel Siurot s/n. 41013, Sevilla, Spain.

Cancer Treatment Reviews
|July 20, 2016
PubMed

Insights

Cancer stem cells (CSCs) drive tumor growth and resist therapy, causing metastasis and recurrence. Targeting CSCs and their microenvironment is crucial for effective cancer treatment and improved clinical outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Cellular Therapeutics

Background:

  • Tumors are driven by cancer stem cells (CSCs), a subpopulation with self-renewal capacity.
  • CSCs are inherently resistant to conventional radio- and chemotherapy.
  • Residual CSCs are linked to cancer metastasis, recurrence, and treatment failure.

Purpose of the Study:

  • To review the mechanisms of cancer stem cell regulation.
  • To discuss how CSC pathways impact therapeutic and clinical outcomes.
  • To highlight the importance of targeting CSCs for cancer treatment.

Main Methods:

  • Literature review of cancer stem cell research.
  • Analysis of CSC characteristics and resistance mechanisms.
  • Discussion of CSC-microenvironment interactions.

Main Results:

  • CSCs possess unique self-renewal and differentiation capabilities.
  • CSCs exhibit significant resistance to standard cancer therapies.
  • The tumor microenvironment actively influences CSC behavior and treatment response.

Conclusions:

  • Eliminating CSCs is a critical goal for successful cancer therapy.
  • Understanding CSC regulatory pathways is key to improving treatment efficacy.
  • Targeting CSCs and their microenvironment holds promise for overcoming therapeutic resistance and preventing recurrence.
Keywords:
CSCCancerConventional therapyMetastasisOxidative stressStem cell therapy

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K